Authors: King, LC Kohan, MJ Brooks, L Nelson, GB Ross, JA Allison, J Adams, L Desai, D Amin, S Padgett, W Lambert, GR Richard, AM Nesnow, S

Citation: Lc. King et al., An evaluation of the mutagenicity, metabolism, and DNA adduct formation of5-nitrobenzo[b]naphtho[2,1-d]thiophene, CHEM RES T, 14(6), 2001, pp. 661-671

Authors: Bordelon, NR Donnelly, KC King, LC Wolf, DC Reeves, WR George, SE

Citation: Nr. Bordelon et al., Bioavailability of the genotoxic components in coal tar contaminated soilsin Fischer 344 rats, TOXICOL SCI, 56(1), 2000, pp. 37-48

Authors: Nesnow, S Davis, C Padgett, WT Adams, L Yacopucci, M King, LC

Citation: S. Nesnow et al., 8,9-Dihydroxy-8,9-dihydrodibenzo[a,l]pyrene is a potent morphological cell-transforming agent in C3H10T(1)/(2)Cl8 mouse embryo fibroblasts in the absence of detectable stable covalent DNA adducts, CARCINOGENE, 21(6), 2000, pp. 1253-1257

Authors: Weidmann, J King, LC Bibbo, M

Citation: J. Weidmann et al., Modification of CytoRich Red fixative system for use on bloody Pap and fine-needle aspiration smears, DIAGN CYTOP, 20(2), 1999, pp. 95-98

Authors: King, LC Adams, L Allison, J Kohan, MJ Nelson, G Desai, D Amin, S Ross, JA

Citation: Lc. King et al., A quantitative comparison of dibenzo[a,I]pyrene-DNA adduct formation by recombinant human cytochrome P450 microsomes, MOL CARCINO, 26(2), 1999, pp. 74-82

Authors: Nesnow, S Davis, C Padgett, W George, M Lambert, G Meyers, F Allison, J Adams, L King, LC

Citation: S. Nesnow et al., Metabolic activation of racemic and enantiomeric trans-8,9-dihydroxy-8,9-dihydrodibenzo[a,l]pyrene (dibenzo[def,p]chrysene) to dibenzo[a,l]pyrene-bis-dihydrodiols by induced rat liver microsomes and a recombinant human P450 1A1 system: The role of the K-region-derived metabolic intermediates in theformation of dibenzo[a,l]pyrene-DNA adducts, CHEM RES T, 11(12), 1998, pp. 1596-1607